12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Disease-specific alteration of karyopherin-α subtype establishes feed-forward oncogenic signaling in head and neck squamous cell carcinoma

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nuclear import, mediated in part by karyopherin-α (KPNA)/importin-α subtypes, regulates transcription factor access to the genome and determines cell fate. However, the cancer-specific changes of KPNA subtypes and the relevancy in cancer biology remain largely unknown. Here, we report that KPNA4, encoding karyopherin-α4 (KPNA4), is exclusively amplified and overexpressed in head and neck of squamous cell carcinoma (HNSCC). Depletion of KPNA4 attenuated nuclear localization signal-dependent transport activity and suppressed malignant phenotypes and induced epidermal differentiation. Mechanistically, KPNA4-mediated nuclear transport of Ras-responsive element-binding protein (RREB1), which sustains Ras/ERK pathway signaling through repressing miR-143/145 expression. Notably, MAPK signaling enhanced trafficking activity of KPNA4 via phosphorylation of KPNA4 at Ser60. These data reveal that KPNA4 establishes a feed-forward cascade that potentiates Ras/ERK signaling in HNSCC.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          Classical nuclear localization signals: definition, function, and interaction with importin alpha.

          The best understood system for the transport of macromolecules between the cytoplasm and the nucleus is the classical nuclear import pathway. In this pathway, a protein containing a classical basic nuclear localization signal (NLS) is imported by a heterodimeric import receptor consisting of the beta-karyopherin importin beta, which mediates interactions with the nuclear pore complex, and the adaptor protein importin alpha, which directly binds the classical NLS. Here we review recent studies that have advanced our understanding of this pathway and also take a bioinformatics approach to analyze the likely prevalence of this system in vivo. Finally, we describe how a predicted NLS within a protein of interest can be confirmed experimentally to be functionally important.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Genomic and molecular characterization of esophageal squamous cell carcinoma

            Esophageal squamous cell carcinoma (ESCC) is a world-wide prevalent cancer, which is particularly common in certain regions of Asia. Here we report the whole-exome or targeted deep sequencing of 139 paired ESCC cases, and analysis of somatic copy number variations (SCNV) of over 180 ESCCs. We identified novel significantly mutated genes such as FAT1, FAT2, ZNF750 and KMT2D, in addition to previously discovered ones (TP53, PIK3CA and NOTCH1). Further SCNV evaluation, immunohistochemistry and biological analysis suggested their functional relevance in ESCC. Notably, RTK-MAPK-PI3K pathways, cell cycle and epigenetic regulation are frequently dysregulated by multiple molecular mechanisms in this cancer. Moreover, our approaches uncovered many novel druggable candidates, and XPO1 was further explored as a therapeutic target because of its mutation and protein overexpression. Together, our integrated study unmasks a number of novel genetic lesions in ESCC and provides an important molecular foundation for understanding esophageal tumors and developing therapeutic targets.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway.

              Although activating mutations in RAS oncogenes are known to result in aberrant signaling through multiple pathways, the role of microRNAs (miRNAs) in the Ras oncogenic program remains poorly characterized. Here we demonstrate that Ras activation leads to repression of the miR-143/145 cluster in cells of human, murine, and zebrafish origin. Loss of miR-143/145 expression is observed frequently in KRAS mutant pancreatic cancers, and restoration of these miRNAs abrogates tumorigenesis. miR-143/145 down-regulation requires the Ras-responsive element-binding protein (RREB1), which represses the miR-143/145 promoter. Additionally, KRAS and RREB1 are targets of miR-143/miR-145, revealing a feed-forward mechanism that potentiates Ras signaling.
                Bookmark

                Author and article information

                Contributors
                +81-0762646206 , masaharu.akj@gmail.com
                +81-0762646253 , rwong@staff.kanazawa-u.ac.jp
                Journal
                Oncogene
                Oncogene
                Oncogene
                Nature Publishing Group UK (London )
                0950-9232
                1476-5594
                10 December 2019
                10 December 2019
                2020
                : 39
                : 10
                : 2212-2223
                Affiliations
                [1 ]ISNI 0000 0001 2308 3329, GRID grid.9707.9, Cell-Bionomics Research Unit, Institute for Frontier Science Initiative, , Kanazawa University, ; Kanazawa, Ishikawa Japan
                [2 ]ISNI 0000 0001 2308 3329, GRID grid.9707.9, Laboratory of Molecular Cell Biology, School of Natural System, Institute of Science and Engineering, , Kanazawa University, ; Kanazawa, Ishikawa Japan
                [3 ]ISNI 0000 0001 2308 3329, GRID grid.9707.9, WPI Nano Life Science Institute, , Kanazawa University, ; Kanazawa, Ishikawa Japan
                [4 ]ISNI 0000 0001 0673 6172, GRID grid.257016.7, Department of Radiation Science, , Hirosaki University Graduate School of Health Sciences, ; 66-1 Hon-cho, Hirosaki, Aomori 036-8564 Japan
                [5 ]ISNI 0000 0001 2308 3329, GRID grid.9707.9, Cancer Model Research Innovative Unit, , Institute for Frontier Science Initiative, Kanazawa University, ; Kanazawa, Japan
                [6 ]ISNI 0000 0001 2152 9905, GRID grid.50956.3f, Department of Medicine, , Cedars-Sinai Medical Center, ; Los Angeles, CA 90048 USA
                [7 ]ISNI 0000 0001 2308 3329, GRID grid.9707.9, Advanced Science Research Center, Institute for Gene Research, , Kanazawa University, ; Kanazawa, Ishikawa Japan
                Author information
                http://orcid.org/0000-0003-2705-9929
                http://orcid.org/0000-0002-2131-6595
                Article
                1137
                10.1038/s41388-019-1137-3
                7056645
                31822798
                0fe1f9f9-859a-4244-92c2-8f02e9818cf8
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 29 March 2019
                : 25 November 2019
                : 27 November 2019
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100001691, MEXT | Japan Society for the Promotion of Science (JSPS);
                Award ID: 17K16332
                Award ID: 80292423
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100003837, Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (Ichiro Kanehara Foundation);
                Funded by: Hokuriku bank foundation for young investigator
                Categories
                Brief Communication
                Custom metadata
                © Springer Nature Limited 2020

                Oncology & Radiotherapy
                cancer genetics,protein transport
                Oncology & Radiotherapy
                cancer genetics, protein transport

                Comments

                Comment on this article